Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Safety and Effectiveness of Edwards Lifesciences SAPIEN 3 Transcatheter Heart Valve (THV) in the Chinese Population

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03466918
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:20.983671+00:00
Published At
2020-07-15T00:00:00+00:00
Record Updated At
2025-09-10
Results Posted At
2020-07-15
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Aortic Stenosis", "Symptomatic Aortic Stenosis", "Aortic Regurgitation"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-09-10"
protocolSection.identificationModule.nctId
"NCT03466918"
protocolSection.identificationModule.officialTitle
"Safety and Effectiveness of Edwards Lifesciences SAPIEN 3 Transcatheter Heart Valve (THV) in the Chinese Population"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2020-07-15"

Study condition terms

  • Aortic Stenosis (protocolSection.conditionsModule.conditions)
  • Symptomatic Aortic Stenosis (protocolSection.conditionsModule.conditions)
  • Aortic Regurgitation (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.